Katrin Engelmann

Katrin Engelmann

Auto-generated profile, based on publicly available information

Katrin Engelmann

Department of Ophthalmology, Klinikum Chemnitz gGmbH, Chemnitz, Germany

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2008 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
TGThomas Götze
Thomas Götze
MVMonika Valtink
Monika Valtink
MNMirko Nitschke
Mirko Nitschke
SGStefan Gramm
Stefan Gramm
THThomas Hanke
Thomas Hanke
Carsten WernerCarsten Werner
Carsten Werner

15 September 1999 in Der Ophthalmologe
Verified
Journal Article
Closed access
PDF file
KEKatrin Engelmann
Katrin Engelmann
JBJürgen Bednarz
Jürgen Bednarz
MBMatthias Böhnke
Matthias Böhnke

25 September 2001 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
TMTorben Møller-Pedersen
Torben Møller-Pedersen
UHUlrike Hartmann
Ulrike Hartmann
NENiels Ehlers
Niels Ehlers
KEKatrin Engelmann
Katrin Engelmann

1 February 2020 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
OFOlga Furashova
Olga Furashova
KEKatrin Engelmann
Katrin Engelmann
Purpose: To evaluate the outcome of macular surgery with ILM- and epiretinal membrane peel associated with significant dry age-related macular degeneration (AMD) as defined by the Age-Related Eye Disease Study (AREDS). Patients and Methods: Institutional. Retrospective case-control study. A total of 42 pseudophacic eyes of 39 patients (7 with full thickness macular hole and 35 with epiretinal membrane) with coexisting dry AMD underwent pars plana vitrectomy (PPV) with internal limiting membrane (ILM) and epiretinal membrane peel. Preoperative and postoperative data including best corrected visual acuity (BCVA), AMD grade according to AREDS, central retinal thickness (CRT), development of choroidal neovascularization (CNV), and central retinal atrophy have been evaluated. Twenty-eight fellow eyes with dry AMD of the included 39 patients served as a control group. Results: A significant improvement in the visual acuity could be observed after surgery (initial BCVA 0.47± 0.31 logarithm of the minimal angle of resolution (logMAR) vs 0.33± 0.29logMAR 9 months postoperatively; p=0.006). CRT decreased significantly after surgery (p< 0.001). In the surgery group, there were 4 eyes (9.5%) with CNV and 1 eye (2.5%) with new central retinal atrophy development after surgery. All these eyes had preoperative AREDS 3 (4 eyes) or AREDS 4 (1 eye) AMD category. In the control group, there was 1 eye (4%) with CNV and 4 eyes (14%) with new central retinal atrophy development during the follow-up of 9 months. These eyes had initially AREDS 2 (1 eye), AREDS 3 (3 eyes) or AREDS 4 (1 eye) AMD category. Conclusion: Eyes with dry AMD of AREDS 3 and AREDS 4 with coexisting VMI abnormalities improve significantly after PPV with membrane peel. While there is a higher risk of CNV development after surgery (9.5%) in these eyes, the vitrectomy does not seem to accelerate central retinal atrophy progression compared to the fellow eyes course.

23 March 2011 in Klinische Monatsblätter für Augenheilkunde
Verified
Journal Article
Closed access
PDF file
KEK. Engelmann
K. Engelmann
MVMonika Valtink
Monika Valtink
DLDirk Lindemann
Dirk Lindemann
MNM. Nitschke
M. Nitschke
Hintergrund: Die Endothel-Keratoplastik ist ein vielversprechendes Verfahren, welches den Vorteil bietet, z. B. bei Erkrankungen, die ausschließlich das korneale Endothel betreffen, lediglich den posterioren Anteil der Hornhaut zu ersetzen. Dieses Verfahren kann postoperative Astigmatismen und möglicherweise auch Abstoßungen vermeiden helfen. Methoden und Ergebnisse: Das chirurgische Verfahren konnte klinisch an einzelnen Zentren bereits gut etabliert werden. Allerdings zeigen die Publikationen zu dem Thema, dass das Problem des postoperativen Endothelzellverlusts ähnlich gravierend oder z. T. noch problematischer als bei der perforierenden Keratoplastik ist. Während die Verbesserung der chirurgischen Verfahren zur Endothel-Keratoplastik zu einer Reduzierung des Endothelzellverlusts führten, gibt es kaum zellbiologische oder gentechnische Ansätze, um den Endothelverlust von Spenderhornhäuten oder Endothellamellen ganz zu verhindern oder die Endothelzelldichte sogar zu erhöhen. Diskussion: Der Übersichtsartikel beschreibt den klinischen Stand der Endothel-Keratoplastik und beschreibt eigene und weltweite Forschungsansätze, die zukünftig helfen können, den Endothelzellverlust zu vermeiden, wie die Entwicklung geeigneter Gewebekulturbedingungen oder die genetische Manipulation des Hornhautendothels. Weiterhin werden Ansätze aus dem Bereich des Tissue Engineerings beschrieben, welche auf die Entwicklung eines transplantierbaren Endothelzell-Sheets zielen. Schlussfolgerung: Vor dem Hintergrund der begrenzten Verfügbarkeit von Spenderhornhäuten müssen zellbiologische Grundlagen des kornealen Endothels und Ansätze des Tissue Engineerings deutlich mehr in den Fokus der Forschung rücken. Methoden zur Vermeidung von Endothelzellverlusten, aber auch zur Erhöhung der Endothelzelldichte sind notwendig und erfordern interdisziplinäre Forschungsansätze. Background: Endothelial keratoplasty is a promising surgical procedure which may replace penetrating keratoplasty in cases of endothelial cell diseases of the cornea. This method may thereby help to prevent postoperative astigmatism and transplant rejection. Methods and Results: A survey of publications reporting about results after endothelial keratoplasty shows that the main problem of this transplantation technique is a postoperative endothelial cell loss which is comparable to or even higher than that observed in penetrating keratoplasty. Improving surgical techniques led to a reduction of the endothelial cell loss, however, cell-based strategies to prevent postoperative cell loss or to enhance the cell densities of donor corneas or endothelial lamellae are rare. Discussion: This review presents an overview of clinical results after endothelial keratoplasty. Current strategies in the field of cell biology and tissue cultivation of corneal endothelial cells, genetic manipulation of the corneal endothelium and tissue engineering strategies aiming at the production of transplantable endothelial cell sheets are described. Conclusion: The limited availability of donor corneas makes it mandatory to develop methods in the field of tissue engineering in order to improve corneal endothelial cell survival or to increase corneal endothelial cell density, using interdisciplinary approaches.

11 August 2009
Verified
Book Chapter
Closed access
PDF file
PWPetra Welzel
Petra Welzel
MNM. Nitschke
M. Nitschke
UFU. Freudenberg
U. Freudenberg
AZA. Zieris
A. Zieris
TGT. Götze
T. Götze
Carsten WernerCarsten Werner
Carsten Werner